<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-045687</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Gamma knife® radiosurgery treatment of trigeminal neuralgia and atypical facial pain</dc:title>
<dc:description xml:lang="en">Introduction. Typical trigeminal neuralgia (TTN) is a condition that is treated initially by pharmacological meansand, if this fails, with different surgical techniques. With the advent of radiosurgery a relatively bloodless form of treatment withlow toxicity and good results has become available and can be considered for use as the first choice procedure. Aims. Our aimwas to report the findings obtained from treating this pathology using Gamma Knife radiosurgery in order to assess thepossibility of using it for patients with neuralgia associated to multiple sclerosis (MS) or who have atypical facial pain (AFP).We also assessed the patients who were re-treated owing to recurrence or persistence. Patients and methods. The sample wasmade up of 74 patients, including seven cases of lesions in the brain stem at the nerve entry point, 45 cases of associatedvascular compression, 15 cases of AFP and eight cases of re-treatment. The median maximum dose was 84 Gy (60.2-120). Themean follow-up time was 23.26 months (1-97.83). Results. Of those with TTN, 76.2% of subjects had no pain at the end ofthe study (75% in cases of second treatments, 69% in cases of associated vascular compression, 52% of those with priorinterventions and 43% with MS), and 33% in the case of AFP. The mean time elapsed before pain disappeared was 4.34 months(0-23.72). Sensitivity was newly affected in 20.3% of patients with TTN or AFP. Conclusions. Gamma Knife radiosurgery is afirst choice therapeutic option for use with patients who have TTN or AFP, as well as in cases of neuralgia associated to MS. Itcan also be considered for use as re-treatment with a tolerable rate of morbidity</dc:description>
<dc:creator>Bravo, G</dc:creator>
<dc:creator>Martínez-Moreno, N. E</dc:creator>
<dc:creator>Burzaco-Santurtún, J</dc:creator>
<dc:creator>Gutiérrez-Sárraga, J</dc:creator>
<dc:creator>Martínez-Álvarez, R</dc:creator>
<dc:creator>Rey-Portolés, G</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. La neuralgia típica del trigémino (NTT) esuna patología tratada en primera instancia farmacológicamente y,si esto fracasa, con distintas técnicas quirúrgicas. Con la llegadade la radiocirugía, se puede optar por un tratamiento poco cruentocon escasa toxicidad y buenos resultados que puede plantearse comoprimera alternativa. Objetivo. Presentar los resultados obtenidosal tratar esta patología mediante radiocirugía con GammaKnife de manera que se valore su posible uso también para pacientescon neuralgia asociada a esclerosis múltiple (EM) o afectos dedolor facial atípico (DFA). También evaluamos a los pacientes retratadospor recidiva o persistencia. Pacientes y métodos. 74 pacientes,incluidos siete casos con lesiones en el tronco cerebral enla entrada del nervio, 45 compresiones vasculares asociadas, 15 casosde DFA y ocho retratamientos. La dosis máxima media ha resultado84 Gy (60,2-120). El seguimiento medio ha sido de 23,26meses (1-97,83). Resultados. En la NTT, un 76,2% no presentabadolor al cierre del estudio (un 75% en segundos tratamientos, un 69%en casos de compresión vascular asociada, un 52% con intervencionesprevias y un 43% con EM) y 33% en casos de DFA. El tiempomedio para la desaparición del dolor fue de 4,34 meses (0-23,72).Hay nuevas alteraciones de la sensibilidad en el 20,3% de pacientescon NTT o DFA. Conclusiones. La radiocirugía con GammaKnife representa una alternativa como primera opción de tratamientoen pacientes con NTT y DFA, así como en la neuralgia asociadaa EM. Incluso puede plantearse como retratamiento con tolerablemorbilidad</dc:description>
<dc:source>Rev Neurol;42(4): 195-201, feb. 2006. ilus, tab, graf</dc:source>
<dc:identifier>ibc-045687</dc:identifier>
<dc:title xml:lang="es">Tratamiento mediante radiocirugía con Gamma Knife de la neuralgia del trigémino y del dolor facial atípico</dc:title>
<dc:subject>^d9296^s22067</dc:subject>
<dc:subject>^d19551^s22009</dc:subject>
<dc:subject>^d28625</dc:subject>
<dc:subject>^d22878</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d14676^s22009</dc:subject>
<dc:subject>^d29853^s22074</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d14676^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>200602</dc:date>
</metadata>
</record>
</ibecs-document>
